Literature DB >> 33590769

Novel biomarkers in cardiovascular surgery.

Raffaele Serra1,2, Federica Jiritano3, Umberto M Bracale4, Nicola Ielapi1,5, Noemi Licastro1,2, Michele Provenzano6, Michele Andreucci6, Antonia Rizzuto2, Pasquale Mastroroberto3, Giuseppe F Serraino3.   

Abstract

Cardiovascular disease includes health problems related to the heart, arteries and veins and is a significant healthcare problem worldwide. Cardiovascular disease may be acute or chronic and relapses are frequent. Biomarkers involved in this field may help clinicians and surgeons in diagnosis and adequate decision making. Relevant articles searched in the following databases Medline, Scopus, ScienceDirect, were retrieved and analysed. Several biomarkers have been identified and we analyzed those of most importance from a clinical and surgical point of view. Biomarkers can better identify high-risk individuals, facilitate follow-up process, provide information regarding prognosis and better tailor the most appropriate surgical treatment.

Entities:  

Keywords:  arteries; biomarkers; cardiovascular; heart; surgery; veins

Mesh:

Substances:

Year:  2021        PMID: 33590769     DOI: 10.2217/bmm-2020-0480

Source DB:  PubMed          Journal:  Biomark Med        ISSN: 1752-0363            Impact factor:   2.851


  3 in total

1.  The neutrophil to lymphocyte ratio and serum albumin as predictors of acute kidney injury after coronary artery bypass grafting.

Authors:  Masashi Ishikawa; Masae Iwasaki; Dai Namizato; Makiko Yamamoto; Tomonori Morita; Yosuke Ishii; Atsuhiro Sakamoto
Journal:  Sci Rep       Date:  2022-09-14       Impact factor: 4.996

2.  Prognostic value of combined preoperative phase angle and handgrip strength in cardiac surgery.

Authors:  Mairi Panagidi; Αndreas S Papazoglou; Dimitrios V Moysidis; Elpiniki Vlachopoulou; Marios Papadakis; Evangelia Kouidi; Antonios Galanos; Georgios Tagarakis; Kyriakos Anastasiadis
Journal:  J Cardiothorac Surg       Date:  2022-09-03       Impact factor: 1.522

3.  Smoking habit as a risk amplifier in chronic kidney disease patients.

Authors:  Michele Provenzano; Raffaele Serra; Ashour Michael; Davide Bolignano; Giuseppe Coppolino; Nicola Ielapi; Giuseppe Filiberto Serraino; Pasquale Mastroroberto; Francesco Locatelli; Luca De Nicola; Michele Andreucci
Journal:  Sci Rep       Date:  2021-07-20       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.